Ledger.Open graph →
SEC Form D · filed August 15, 2023

VIN-41 Neurexis Therapeutics, LLC

Offering
$500K
Sold
$20K
Exemption
Rule 506(b)
Industry
Other
Location
FAYETTEVILLE, AR
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Robert C. Goforth · Fayetteville, ARExecMark C. Wagstaff · Fayetteville, ARExecJames L. Hegyi · Darien, CTExecJustin Bekelman · San Francisco, CAExecMatthew S. Kupersmith · Darien, CTExecWilliam S. Benjamin · Denver, COExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗